Issue N# 1 - 2019
Improving quality of life in subjective tinnitus patients with Audistim®
Authors : Van Becelaere T, Zahti H, Polet T, Glorieux P, Portmann D, Rigaudier F, Herpin F, Decat M. (Bruxelles)
Ref. : Rev Laryngol Otol Rhinol. 2019;140,1:3-7.
Article published in english
Downloadable PDF document english
Objectives: This study aims to improve the quality of life of chronic subjective tinnitus patients with Audistim®. Methodology: It is a prospective study carried out in a Belgian target population, from one university and one regional hospital, suffering from chronic subjective tinnitus. Quality of life was measured by the Tinnitus Handicap Inventory (THI), the quality of sleep by the Pittsburgh Sleep Quality Index (PSQI) and stress by the Psychological Stress Mesure (MSP-9). Results: There is a significant improvement of the quality of life with Audistim® treatment when comparing the initial THI score and the THI score after 3 months of treatment (p-value 0.0000; p-value <0.0001). The initial PSQI score and the post treatment score show a significant improvement (T-test 8.7, p-value <0.01). Within the PSQI scores, especially the latency of sleep (T-test 15.1, p-value <0.001), and the daytime dysfunction (T-test 10.6, p-value <0.01) improved. There was also a slight improvement in sleep disturbance (T-test 4.0, p-value <0.05). The initial MSP-9 score (D0) and the score after Audistim® treatment (M3) show a significant improvement (T-test 7.6, p-value <0.01). Conclusions: There is a general improvement of quality of life when Audistim® is taken on a regular basis for 3 months.
Price : 12.00 €